"Pulmonary and Sleep Disorders"

During the past decade, Southeastern Lung Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Lung Care" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Lung Care" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Asthma" (1 trials), "COPD" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Southeastern Lung Care" in a lesser frequency.

Most popular intervention types in "Southeastern Lung Care" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "BIO-11006" (1 trials), "BIO-11006 Inhalation Solution" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Lung Care" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Lung Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southeastern Lung Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Lung Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".